Sonoma Pharmaceuticals, Inc. – ‘S-1’ on 11/21/14 – ‘R40’

On:  Friday, 11/21/14, at 5:30pm ET   ·   Accession #:  1019687-14-4450   ·   File #:  333-200461

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Oculus Innovative Sciences, Inc.                    HTML   1.24M 
 2: EX-23.1     Consent of Experts or Counsel                       HTML     18K 
40: R1          Document and Entity Information                     HTML     44K 
30: R2          Condensed Consolidated Balance Sheets               HTML    116K 
38: R3          Condensed Consolidated Balance Sheets               HTML     41K 
                (Parenthetical)                                                  
42: R4          Condensed Consolidated Statements of Comprehensive  HTML    113K 
                Loss (Unaudited)                                                 
55: R5          Consolidated Statements of Changes in               HTML     91K 
                Stockholders' Equity                                             
32: R6          Condensed Consolidated Statements of Cash Flows     HTML    135K 
                (Unaudited)                                                      
37: R7          1. Organization and Basis of Presentation           HTML     84K 
27: R8          2. Liquidity and Going Concern                      HTML     31K 
18: R9          3. Summary of Significant Accounting Policies       HTML    154K 
56: R10         4. Condensed Consolidated Balance Sheets            HTML     25K 
44: R11         5. Derivative Liabilities                           HTML     95K 
43: R12         6. Commitments and Contingencies                    HTML     75K 
48: R13         7. Stockholders' Equity                             HTML     53K 
49: R14         8. Stock-Based Compensation                         HTML    114K 
47: R15         9. Income Taxes                                     HTML     66K 
50: R16         10. Segment and Geographic Information              HTML     46K 
39: R17         11. Significant Customer Concentrations             HTML     25K 
41: R18         12. Subsequent Events                               HTML     29K 
46: R19         4. Accounts Receivable (March 2014 note)            HTML     32K 
60: R20         5. Inventories (March 2014 note)                    HTML     31K 
52: R21         6. Prepaid Expenses and Other Current Assets        HTML     24K 
                (March 2014 note)                                                
34: R22         7. Property and Equipment (March 2014 note)         HTML     30K 
45: R23         8. Investment in Ruthigen, Inc. (March 2014 note)   HTML     50K 
36: R24         9. Accrued Expenses and Other Current Liabilities   HTML     25K 
                (March 2014 note)                                                
14: R25         10. Long-Term Debt (March 2014 note)                HTML     41K 
53: R26         16. Employee Benefit Plan (March 2014 note)         HTML     21K 
57: R27         3. Summary of Significant Accounting Policies       HTML    119K 
                (Policies)                                                       
23: R28         3. Summary of Significant Accounting Policies       HTML     39K 
                (Tables)                                                         
22: R29         4. Condensed Consolidated Balance Sheets (Tables)   HTML     25K 
25: R30         5. Derivative Liabilities (Tables)                  HTML     46K 
26: R31         8. Stock-Based Compensation (Tables)                HTML     60K 
28: R32         10. Segment and Geographic Information (Tables)     HTML     31K 
13: R33         2. Liquidity and Financial Condition (Details       HTML     29K 
                Narrative)                                                       
51: R34         3. Summary of Significant Accounting Policies       HTML     22K 
                (Details - Potentially Dilutive Securities)                      
33: R35         3. Summary of Significant Accounting Policies -     HTML     27K 
                Financial liabilities (Details)                                  
35: R36         3. Summary of Significant Accounting Policies       HTML     22K 
                (Details Narrative)                                              
16: R37         4. Condensed Consolidated Balance Sheets (Details   HTML     21K 
                - Inventories)                                                   
59: R38         5. Derivative Liabilities (Details - Valuation      HTML     43K 
                Assumptions)                                                     
 9: R39         5. Derivative Liabilities (Details - Changes in     HTML     26K 
                fair value)                                                      
29: R40         6. Commitments and Contingencies (Details -         HTML     34K 
                Assumptions)                                                     
54: R41         6. Commitments and Contingencies (Details           HTML     39K 
                Narrative)                                                       
15: R42         7. Stock holders' Equity (Details Narrative)        HTML     30K 
21: R43         8. Stock-Based Compensation (Details - Allocated    HTML     23K 
                Share-Based Compensation Expense)                                
24: R44         8. Stock-Based Compensation (Details - Options      HTML     62K 
                Outstanding)                                                     
31: R45         8. Stock-Based Compensation (Details Narrative)     HTML     33K 
12: R46         10. Segment and Geographic Information (Details)    HTML     22K 
17: R47         10. Segment and Geographic Information (Details     HTML     25K 
                Narrative)                                                       
10: R48         11. Significant Customer Concentrations (Details    HTML     23K 
                Narrative)                                                       
58: XML         IDEA XML File -- Filing Summary                      XML     91K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX    201K 
20: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    889K 
 3: EX-101.INS  XBRL Instance -- ocls-20140930                       XML   1.41M 
 5: EX-101.CAL  XBRL Calculations -- ocls-20140930_cal               XML    136K 
 6: EX-101.DEF  XBRL Definitions -- ocls-20140930_def                XML    281K 
 7: EX-101.LAB  XBRL Labels -- ocls-20140930_lab                     XML    671K 
 8: EX-101.PRE  XBRL Presentations -- ocls-20140930_pre              XML    502K 
 4: EX-101.SCH  XBRL Schema -- ocls-20140930                         XSD    112K 
19: ZIP         XBRL Zipped Folder -- 0001019687-14-004450-xbrl      Zip    143K 

‘R40’   —   6. Commitments and Contingencies (Details – Assumptions)

This is an IDEA Financial Report.  [ Alternative Formats ]

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1’ Filing		Date		Other Filings
Filed on:		11/21/14
		9/30/14		10-Q
		9/30/13		10-Q,  NT 10-Q
				List all Filings